• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Karyopharm Therapeut (NQ: KPTI )

    0.8700 -0.0200 (-2.25%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 740,747
    Open 0.9000
    Bid (Size) 0.8600 (10)
    Ask (Size) 0.8700 (3)
    Prev. Close 0.8900
    Today's Range 0.8521 - 0.9012
    52wk Range 0.6174 - 1.950
    Shares Outstanding 114,010,448
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript
    KPTI earnings call for the period ending June 30, 2024. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial

    Performance

    YTD
    -3.46%
    -3.46%
    1 Month
    +19.15%
    +19.15%
    3 Month
    +10.11%
    +10.11%
    6 Month
    -35.56%
    -35.56%
    1 Year
    -30.95%
    -30.95%

    More News

    Read More
    KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
    Via InvestorPlace
    Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    Karyopharm Therapeutics's Earnings: A Preview
    Via Benzinga
    Earnings Preview For Karyopharm Therapeutics
    Via Benzinga
    6 Analysts Have This to Say About Karyopharm Therapeutics
    Via Benzinga
    KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Stocks That Hit 52-Week Lows On Wednesday
    Via Benzinga
    Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript
    Via The Motley Fool
    Karyopharm's Selinexor Shows Progression-Free Survival of 27.4 Months In Endometrial Cancer With Certain Mutation
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Via Benzinga
    CMG Stock Alert: Chipotle Announces International Expansion Plan
    Via InvestorPlace
    Why Are Karyopharm Therapeutics Shares Gaining Today?
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Is CEL-SCI (CVM) Stock Down 23% Today?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.